Pear Therapeutics
The newly released PDTs, now RESET and RESET-O, deliver a self-directed, 12-week course of cognitive behavioral therapy that incentivizes patients to conform to treatment.
Sigurjon Kristjansson, CEO of Nox Health, tells MobiHealthNews why his company made the largest bid for Pear Therapeutics' assets at a recent bankruptcy auction
The prescription digital therapeutics company's assets were sold to four bidders: Click Therapeutics, Harvest BIO, Nox Health Group and Welt.
The prescription digital therapeutics company is pursuing a sale of the business or its assets.
Without a transaction, the prescription digital therapeutics company said it may need to reorganize or liquidate.
Patients can access Pear's reSET for substance use disorder and reSET-O for opioid use disorder.
Spero Health will widen its use of Pear's reSET and reSET-O prescription digital therapeutics from 14 clinics in Kentucky to 99 locations in five other states.
Execs said investors will focus on companies with evidence of market fit, established business models and those achieving measurable health outcomes.
The year was plagued by layoffs, slowing investments and an increased need for companies to prove their market value.
The execs spotlight the year's rise of home healthcare, drop in digital health investment and expanded use of AI, in addition to the value of virtual care.